214 related articles for article (PubMed ID: 2846159)
1. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.
Thompson EW; Reich R; Shima TB; Albini A; Graf J; Martin GR; Dickson RB; Lippman ME
Cancer Res; 1988 Dec; 48(23):6764-8. PubMed ID: 2846159
[TBL] [Abstract][Full Text] [Related]
2. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
[TBL] [Abstract][Full Text] [Related]
3. The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.
Tong GM; Rajah TT; Zang XP; Pento JT
Anticancer Res; 2002; 22(1A):103-6. PubMed ID: 12017270
[TBL] [Abstract][Full Text] [Related]
4. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
5. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
7. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Müller V; Jensen EV; Knabbe C
Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
9. Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells.
Rajah TT; Pento JT
Cancer Invest; 1999; 17(1):10-8. PubMed ID: 10999044
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
[TBL] [Abstract][Full Text] [Related]
11. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
13. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Osborne CK; Boldt DH; Estrada P
Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
[TBL] [Abstract][Full Text] [Related]
14. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
[TBL] [Abstract][Full Text] [Related]
15. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
Butler WB; Fontana JA
Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259
[TBL] [Abstract][Full Text] [Related]
16. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
Poulin R; Merand Y; Poirier D; Levesque C; Dufour JM; Labrie F
Breast Cancer Res Treat; 1989 Oct; 14(1):65-76. PubMed ID: 2605344
[TBL] [Abstract][Full Text] [Related]
18. Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Cancer Chemother Pharmacol; 1996; 38(3):238-44. PubMed ID: 8646798
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
[TBL] [Abstract][Full Text] [Related]
20. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
Journe F; Chaboteaux C; Magne N; Duvillier H; Laurent G; Body JJ
Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
